Mapping the Binding of GluN2B-Selective N-Methyl-D-aspartate Receptor Negative Allosteric Modulators

被引:40
|
作者
Burger, Pieter B. [1 ]
Yuan, Hongjie [2 ]
Karakas, Erkan [3 ]
Geballe, Matthew [1 ]
Furukawa, Hiro [3 ]
Liotta, Dennis C. [1 ]
Snyder, James P. [1 ]
Traynelis, Stephen F. [2 ]
机构
[1] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Pharmacol, Atlanta, GA USA
[3] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
基金
美国国家卫生研究院;
关键词
AMINO-TERMINAL DOMAIN; ANTI-ISCHEMIC AGENTS; NMDA RECEPTOR; NR2B SUBUNIT; ANTAGONIST PROPERTIES; PI INTERACTIONS; IFENPRODIL; PROTEIN; SUBTYPE; MECHANISMS;
D O I
10.1124/mol.112.078568
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have used recent structural advances in our understanding of the N-methyl-D-aspartate (NMDA) receptor amino terminal domain to explore the binding mode of multiple diaryl GluN2B-selective negative allosteric modulators at the interface between the GluN1 and GluN2B amino-terminal domains. We found that interaction of the A ring within the binding pocket seems largely invariant for a variety of structurally distinct ligands. In addition, a range of structurally diverse linkers between the two aryl rings can be accommodated by the binding site, providing a potential opportunity to tune interactions with the ligand binding pocket via changes in hydrogen bond donors, acceptors, as well as stereochemistry. The most diversity in atomic interactions between protein and ligand occur in the B ring, with functional groups that contain electron donors and acceptors providing additional atomic contacts within the pocket. A cluster of residues distant to the binding site also control ligand potency, the degree of inhibition, and show ligand-induced increases in motion during molecular dynamics simulations. Mutations at some of these residues seem to distinguish between structurally distinct ligands and raise the possibility that GluN2B-selective ligands can be divided into multiple classes. These results should help facilitate the development of well tolerated GluN2B subunit-selective antagonists.
引用
收藏
页码:344 / 359
页数:16
相关论文
共 50 条
  • [1] A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists
    Liu, Wenwu
    Jiang, Xiaowen
    Zu, Yuxin
    Yang, Yue
    Liu, Yaqian
    Sun, Xue
    Xu, Zihua
    Ding, Huaiwei
    Zhao, Qingchun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
  • [2] Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist
    Garner, Rachel
    Gopalakrishnan, Shobha
    McCauley, John A.
    Bednar, Rodney A.
    Gaul, Stanley L.
    Mosser, Scott D.
    Kiss, Laszlo
    Lynch, Joseph J.
    Patel, Shil
    Fandozzi, Christine
    Lagrutta, Armando
    Briscoe, Richard
    Liverton, Nigel J.
    Paterson, Blake M.
    Vornov, James J.
    Mazhari, Reza
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (06): : 1 - 12
  • [3] Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the N-Methyl-d-aspartate Receptor
    D'Erasmo, Michael P.
    Akins, Nicholas S.
    Ma, Peipei
    Jing, Yao
    Swanger, Sharon A.
    Sharma, Savita K.
    Bartsch, Perry W.
    Menaldino, David S.
    Arcoria, Paul J.
    Bui, Thi-Thien
    Pons-Bennaceur, Alexandre
    Le, Phuong
    Allen, James P.
    Ullman, Elijah Z.
    Nocilla, Kelsey A.
    Zhang, Jing
    Perszyk, Riley E.
    Kim, Sukhan
    Acker, Timothy M.
    Taz, Azmain
    Burton, Samantha L.
    Coe, Kevin
    Fritzemeier, Russell G.
    Burnashev, Nail
    Yuan, Hongjie
    Liotta, Dennis C.
    Traynelis, Stephen F.
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (17): : 3059 - 3076
  • [4] Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit
    Buemi, Maria Rosa
    De Luca, Laura
    Ferro, Stefania
    Russo, Emilio
    De Sarro, Giovambattista
    Gitto, Rosaria
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (07) : 1513 - 1519
  • [5] Structure-activity relationship of a tetrahydroisoquinoline class of N-methyl-D-aspartate receptor modulators that potentiates GluN2B-containing N-methyl-D-aspartate receptors
    Epplin, Matthew
    Strong, Katie
    Bacsa, John
    Butch, Christopher
    Burger, Pieter
    Menaldino, David
    Traynelis, Stephen
    Liotta, Dennis
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [6] Phase 1 Clinical Results for NP10679, a pH-sensitive GluN2B-selective N-methyl-d-aspartate Receptor Inhibitor
    Zaczek, Robert
    Traynelis, Stephen F.
    Dingledine, Ray
    Koszalka, George W.
    Laskowitz, Daniel T.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (07): : 706 - 717
  • [7] Synthesis and preliminary evaluation of novel11C-labeled GluN2B-selective NMDA receptor negative allosteric modulators
    Sun, Ji-yun
    Kumata, Katsushi
    Chen, Zhen
    Zhang, Yi-ding
    Chen, Jia-hui
    Hatori, Akiko
    Fu, Hua-long
    Rong, Jian
    Deng, Xiao-yun
    Yamasaki, Tomoteru
    Xie, Lin
    Hu, Kuan
    Fujinaga, Masayuki
    Yu, Qing-zhen
    Shao, Tuo
    Collier, Thomas Lee
    Josephson, Lee
    Shao, Yi-han
    Du, Yun-fei
    Wang, Lu
    Xu, Hao
    Zhang, Ming-rong
    Liang, Steven H.
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (03) : 491 - 498
  • [8] Evaluation of allosteric N-methyl-D-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modeling
    Lotti, James S.
    Jones, Jaron
    Farnsworth, Jill C.
    Yi, Feng
    Zhao, Fabao
    Menniti, Frank S.
    Volkmann, Robert A.
    Clausen, Rasmus P.
    Hansen, Kasper B.
    MOLECULAR PHARMACOLOGY, 2025, 107 (01)
  • [9] Mechanism for Noncompetitive Inhibition by Novel GluN2C/D N-Methyl-D-aspartate Receptor Subunit-Selective Modulators
    Acker, Timothy M.
    Yuan, Hongjie
    Hansen, Kasper B.
    Vance, Katie M.
    Ogden, Kevin K.
    Jensen, Henrik S.
    Burger, Pieter B.
    Mullasseril, Praseeda
    Snyder, James P.
    Liotta, Dennis C.
    Traynelis, Stephen F.
    MOLECULAR PHARMACOLOGY, 2011, 80 (05) : 782 - 795
  • [10] Synthesis and preliminary evaluation of novel 11C-labeled GluN2B-selective NMDA receptor negative allosteric modulators
    Ji-yun Sun
    Katsushi Kumata
    Zhen Chen
    Yi-ding Zhang
    Jia-hui Chen
    Akiko Hatori
    Hua-long Fu
    Jian Rong
    Xiao-yun Deng
    Tomoteru Yamasaki
    Lin Xie
    Kuan Hu
    Masayuki Fujinaga
    Qing-zhen Yu
    Tuo Shao
    Thomas Lee Collier
    Lee Josephson
    Yi-han Shao
    Yun-fei Du
    Lu Wang
    Hao Xu
    Ming-rong Zhang
    Steven H Liang
    Acta Pharmacologica Sinica, 2021, 42 : 491 - 498